Artiva Biotherapeutics, Inc. ARTV Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $21.42M-21.2% | $27.16M+4.6% | $25.97M-10.2% | $28.93M-6.3% | $30.86M-23.8% | ||
| $65.83M-19.0% | $81.31M-16.6% | $97.46M-14.4% | $113.9M-16.0% | $135.56M— | ||
| $88.74M-21.2% | $112.67M-13.0% | $129.52M-13.1% | $149.07M-12.3% | $170M— | ||
| $6.22M-6.1% | $6.62M-5.2% | $6.98M+1.4% | $6.89M-2.4% | $7.06M— | ||
| $105.96M-19.1% | $130.94M-12.0% | $148.86M-12.1% | $169.39M-11.4% | $191.26M— | ||
| $4.7M+5.6% | $4.45M-14.7% | $5.22M-6.6% | $5.59M+7.5% | $5.2M+29.6% | ||
| $11K-75.0% | $44K-41.3% | $75K-29.2% | $106K-15.9% | $126K— | ||
| $10.88M-16.9% | $13.09M+17.7% | $11.12M+3.3% | $10.77M-11.8% | $12.2M— | ||
| $18.11M-13.6% | $20.97M+6.8% | $19.64M-3.5% | $20.35M-9.5% | $22.48M— | ||
| —— | —— | —— | —— | —— | ||
| -$354.07M-7.1% | -$330.55M-6.7% | -$309.78M-7.5% | -$288.25M-8.0% | -$267M— | ||
| $87.85M-20.1% | $109.97M-14.9% | $129.22M-13.3% | $149.04M-11.7% | $168.78M-9.6% | ||
| $105.96M-19.1% | $130.94M-12.0% | $148.86M-12.1% | $169.39M-11.4% | $191.26M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Artiva Biotherapeutics, Inc.'s total assets?
- Artiva Biotherapeutics, Inc. (ARTV) holds $106.0M in total assets, down 44.6% year over year.
- How much debt does Artiva Biotherapeutics, Inc. have?
- Artiva Biotherapeutics, Inc. carries $10.3M in total debt against $87.8M of shareholders' equity, a debt-to-equity ratio of 0.12.
- How much cash does Artiva Biotherapeutics, Inc. have?
- Artiva Biotherapeutics, Inc. holds $21.4M in cash and equivalents.
- Can Artiva Biotherapeutics, Inc. cover its short-term obligations?
- Its current ratio is 8.16 — current assets exceed current liabilities.
- Where does Artiva Biotherapeutics, Inc.'s balance sheet data come from?
- Every line is extracted from Artiva Biotherapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.